Search Within

Xin Pei

Formats
  1. Journal Article (71)
  2. Meeting Abstract (65)
Groups
  1. Sloan Kettering Institute Postdocs (136)
  2. Radiation Oncology, Department of (125)
  3. Survivorship Research (96)
  4. Gynecology Disease Management Team (88)
  5. GDMT, Radiation Oncology (69)
  6. GSK Faculty (51)

More Groups

People
  1. Michael Zelefsky (79)
  2. Marisa Kollmeier (65)
  3. Nadeem Riaz (41)
  4. Yoshiya Yamada (38)
  5. Zhigang Zhang (32)
  6. Brett Cox (29)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (59)
  2. Brachytherapy (8)
  3. Journal of Clinical Oncology (6)
  4. Annals of Oncology (5)
  5. BJU International (5)
  6. European Urology (5)

More Publications

Publishers
  1. Elsevier Inc. (65)
  2. Elsevier Science, Inc. (20)
  3. Oxford University Press (9)
  4. American Society of Clinical Oncology (8)
  5. Nature Publishing Group (7)
  6. Wiley Blackwell (6)

More Publishers

Results (136)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Endometrial cancers in BRCA1 or BRCA2 germline mutation carriers: Assessment of homologous recombination DNA repair defects
    Journal Article

    Smith, E. S.; Da Cruz Paula, A.; Cadoo, K. A.; Abu-Rustum, N. R.; Pei, X.; Brown, D. N.; Ferrando, L.; Sebastiao, A. P. M.; Riaz, N.; Robson, M. E.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers
    Journal Article

    Mandelker, D.; Kumar, R.; Pei, X.; Selenica, P.; Setton, J.; Arunachalam, S.; Ceyhan-Birsoy, O.; Brown, D. N.; Norton, L.; Robson, M. E.; more...
    JNCI Cancer Spectrum (2019)

    Fulltext@MSK | Save
  • Are endometrial cancers arising in BRCA1/BRCA2 germline mutations carriers true BRCA1/BRCA2 cancers?
    Meeting Abstract

    Da Cruz Paula, A.; Smith, E.; Cadoo, K.; Abu-Rustum, N.; Pei, X.; Riaz, N.; Robson, M.; Reis-Filho, J.; Mandelker, D.; Weigelt, B.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Are endometrial cancers arising in BRCA1/BRCA2 germline mutations carriers true BRCA1/BRCA2 cancers?
    Meeting Abstract

    Da Cruz Paula, A.; Smith, E.; Cadoo, K.; Abu-Rustum, N.; Pei, X.; Riaz, N.; Robson, M.; Reis-Filho, J.; Mandelker, D.; Weigelt, B.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers
    Meeting Abstract

    Kumar, R.; Pei, X.; Selenica, P.; Wen, H. Y.; Powell, S.; Robson, M.; Riaz, N.; Reis-Filho, J. S.; Weigelt, B.; Mandelker, D.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Dose-escalated intensity modulated radiation therapy for prostate cancer: 15-year outcomes data
    Journal Article

    Weg, E. S.; Pei, X.; Kollmeier, M. A.; McBride, S. M.; Zelefsky, M. J.
    Advances in Radiation Oncology (2019)

    Fulltext@MSK | Save
  • Long-term implications of a positive posttreatment biopsy in patients treated with external beam radiotherapy for clinically localized prostate cancer
    Journal Article

    Zelefsky, M. J.; Goldman, D. A.; Reuter, V.; Kollmeier, M.; McBride, S.; Zhang, Z.; Varghese, M.; Pei, X.; Fuks, Z.
    Journal of Urology (2019)

    Fulltext@MSK | Save
  • Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression
    Journal Article

    Ashley, C. W.; Da Cruz Paula, A.; Kumar, R.; Mandelker, D.; Pei, X.; Riaz, N.; Reis-Filho, J. S.; Weigelt, B.
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Phosphatidylinositol-3-kinase mutations are associated with increased local failure in brain metastases treated with radiation
    Journal Article

    Lockney, N. A.; Wang, D. G.; Pei, X.; Goldman, D. A.; Zhang, Z.; Lin, A.; Chan, T. A.; Yamada, Y.; Beal, K.; Yang, T. J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Prostate-specific antigen (PSA) bounce after dose-escalated external beam radiation therapy is an independent predictor of PSA recurrence, metastasis, and survival in prostate adenocarcinoma patients
    Journal Article

    Romesser, P. B.; Pei, X.; Shi, W.; Zhang, Z.; Kollmeier, M.; McBride, S. M.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save